Submit Feedback

Pfizer Overview

Company: Pfizer
CEO: Dr. Albert Bourla D.V.M., Ph.D.
Symbol: PFE
Exchange: NYSE
Industry: Drug Manufacturers - General
Sector: Healthcare
About

Pfizer discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas,luding cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas Pfizer was founded in 1849 and is headquartered in New York, New York.

Continue reading...
  • Address:

    235 East 42nd Street

  • City | State | Zip | Country:

    New York | NY | 10017 | US

  • Phone:

    212 733 2323

  • Website:

    https://www.pfizer.com

Pfizer (PFE)

  • Stock Price
  • Volume
26.86 -10.57 -28.24%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Net Income

Employees

Revenue by Segment

Revenue by Region

Income Statement

Operating Income

Research & Development

Tax Rate (%)

Assets & Liabilities | Cash Flow

Total Assets

Total Liabilities

Capital Expenditure

Ratios

Return on Equity (ROE)

Return on Assets (ROA)

Debt to Equity

Profitability

Gross Profit Margin (%)

Operating Income Margin (%)

Net Income Margin (%)

Earning Per Share

EBITDA

Free Cash Flow (FCF)

Valuation

Enterprise value

Enterprise value to Revenue

Enterprise value to EBITDA

Competitors’ Revenue